The investment objective of the Fund is to achieve long-term capital growth through investment in a diversified portfolio of quoted equity investments principally in companies incorporated in any European country (including the UK and Eastern Europe) or in companies that have a significant proportion of their assets or interests in Europe.
Name | % Net Assets |
---|---|
30 Year German Bund | 12.8% |
Koninklijke KPN | 5.7% |
British American Tobacco | 5.7% |
Imperial Tobacco | 5.7% |
France Telecom | 5.7% |
Roche | 4.5% |
Deutsche Telekom | 4.4% |
Syngenta | 4.0% |
UK Gilt (2055) | 4.0% |
Novo Nordisk | 3.9% |
Key | % Net Assets |
---|---|
30 Year German Bund | 12.8% |
Koninklijke KPN | 5.7% |
British American Tobacco | 5.7% |
Imperial Tobacco | 5.7% |
Other | 70.1% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 03/04/2006 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | 5000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.75% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research